Peer Review History
| Original SubmissionApril 4, 2025 |
|---|
|
Dear Dr. Lucy H. Eddy, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tadashi Ito Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: “The work of the lead author (L.H. Eddy) and co-author (C.E. Staniforth) was supported by a grant from the Waterloo Foundation (ref: 27665413). M. Mon-Williams was supported by a Fellowship from the Alan Turing Institute. The work was conducted within infrastructure provided by the Centre for Applied Education Research (funded by the Department for Education through the Bradford Opportunity Area) and ActEarly: a City Collaboratory approach to early promotion of good health and wellbeing funded by the Medical Research Council (grant reference MR/S037527/). M. Mon-Williams’ involvement was supported by the National Institute for Health Research Yorkshire and Humber ARC (reference: NIHR20016). The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health Research or the Departments of Health and Social Care or Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “The work of the lead author (L.H. Eddy) and co-author (C.E. Staniforth) was supported by a grant from the Waterloo Foundation (ref: 27665413). M. Mon-Williams was supported by a Fellowship from the Alan Turing Institute. The work was conducted within infrastructure provided by the Centre for Applied Education Research (funded by the Department for Education through the Bradford Opportunity Area) and ActEarly: a City Collaboratory approach to early promotion of good health and wellbeing funded by the Medical Research Council (grant reference MR/S037527/). M. Mon-Williams’ involvement was supported by the National Institute for Health Research Yorkshire and Humber ARC (reference: NIHR20016).” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The work of the lead author (L.H. Eddy) and co-author (C.E. Staniforth) was supported by a grant from the Waterloo Foundation (ref: 27665413). M. Mon-Williams was supported by a Fellowship from the Alan Turing Institute. The work was conducted within infrastructure provided by the Centre for Applied Education Research (funded by the Department for Education through the Bradford Opportunity Area) and ActEarly: a City Collaboratory approach to early promotion of good health and wellbeing funded by the Medical Research Council (grant reference MR/S037527/). M. Mon-Williams’ involvement was supported by the National Institute for Health Research Yorkshire and Humber ARC (reference: NIHR20016). The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health Research or the Departments of Health and Social Care or Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. “ Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Review The system is a bit broken…” a qualitative exploration of barriers in the pathway for diagnosing Developmental Coordination Disorder/ Specific Developmental Disorder of Motor Function. Overall, this study is well-written and gives an interesting insight in the perception of professionals regarding the diagnostic pathway which may be related to the intervention opportunities for children with DCD. It has been an extensive study to conduct and process all the information. However, only a small number of participants was included which could not cover the entire district. The authors need to reconsider not to generalize the outcomes, since the level of knowledge amongst other parts of Bradford (and the rest of the UK) can be different. There are only three key-topics extracted which were defined beforehand. What topics came up through the transcription procedure? I wonder why prompts were chosen to be included? By including these you intend to steer the answers? For example budgets/resources are no prompts for PTs or OTs? The paper can improve by making it more appropriate and into line with current international knowledge. 1. Title: The system is a bit broken… if this is one answer on one question of one of your participants, do you believe it completely covers the topic? Besides it is not only aimed at diagnosing, correct? And you were also looking for facilitators? 2. Abstract: the conclusion that “These findings are unlikely to be unique to Bradford and appear to reflect national and international health service challenges” is presented too strongly, without evidence whatsoever. Where do you support ‘appear’ upon? And what is the connection with international situations? Please, rephrase 3. In the DSM5 the neurodevelopmental motor disorders include DCD, stereotypic movement disorder and tic disorders. The term “Specific Developmental Disorder of Motor Function” is hardly used in research and rehabilitation and it is agreed upon that DCD is supposed to be the commonly used term (as confirmed in the first paragraph of the intro). Please, remove SDDMF to increase consistency of the terms being used. You can introduce it in the Method section, since the results confirm that this term is not being used. 4. In the abstract the abbreviations (COM-B model) should be written out in full at first use. 5. Final paragraph in the introduction:”the parental dissatisfaction is consistent with the observation that….” Whose observation? And in what part of the UK was it observed? 6. “sparse insights”? How can you support this or do you have a reference? 7. Design: interviews focused on one district (Bradford). However, I don’t think you can say this since Bradford borough is an enormous district with a huge population. I don’t think interviewing 1 GP would cover the whole area. Please, rewrite and be more specific on the area or maybe the links to a hospital, rehab center or how many schools to know what this qualitative study represents within this huge area. 8. In total 18 stakeholders were recruited: how many were invited? 9. COM-B: please write out in full first time and introduce the model more clearly. Specifically, how you directed capability, as originally referred to an individual’s psychological and physical ability to participate in an activity: which questions were aimed for this process? And which external factors were asked to present the opportunity of which behavior and finally, motivation: which questions referred to the conscious and unconscious cognitive processes that direct and inspire change. Please refer to the first authors that introduced the model. 10. Behaviour Change Wheel: please, again explain or introduce earlier. We need to know how you used this model and based upon this model why you presented the answers you chose to present as results. 11. “This terminology will shift again in ICD-11 (due to become statutory in the UK by 2026) to Developmental Motor Coordination Disorder (28)”. Are you sure you can say this based on the reference of 2022? Since then, it has become common knowledge that DCD is not limited to only motor deficits, but also poor executive functioning (planning, execution, anticipatory control and working memory)? 12. Can you explain what you mean by Pre and post FUNMOVES? This needs some clarification and a reason why you included this in your questions. 13. In the discussion you focus in the second paragraph on opportunity. However, why not start with capability to keep the order consistent? 14. What is an Early Years Curriculum during Key Stage 1 Physical Education: this will probably be known in the UK, but since this journal is an international journal you better explain the content and ages involved. 15. In the third paragraph of the discussion, you only present the fact that there is not enough knowledge regarding diagnosing DCD consistently. It might be good that you at least bring forward the four diagnostic criteria for DCD according to the DSM5 to improve the consistency in diagnosing for DCD. This might be the transfer from the third to fourth paragraph. In some countries these criteria are accepted well by health and educational professionals. 16. “Participants made it clear that we need to move towards a more integrated system, where health and education work synchronously to provide early and consistent support for sensorimotor skill difficulties, without having to rely on a diagnosis to trigger support systems.” This may be one side of the coin, the other is that many children feel for the first time ‘understood’ when they understand what DCD means. Many parents wished they would have known this many years before, to prevent them from becoming angry with their ‘clumsy’ child. Knowledge for the parents and children is the most important factor that interferes with self-esteem and preventing anxiety or depression when becoming grown-ups. You may give this as a limitation, since your interviews were not directed at parents of children with DCD or children with DCD. 17. The future directions do not take into account that DCD will not be overgrown and needs understanding of the developing child and their parents and environments. Why not? 18. I am not sure where the evidence based training comes from, since this is not the scope of this paper. 19. Limitations: number of participants is small and very variable, please address. 20. These results cannot account for the whole of the district. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Dorothee Jelsma ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
“The system is a bit broken…” a qualitative exploration of barriers in the pathway for diagnosing Developmental Coordination Disorder PONE-D-25-16312R1 Dear Dr. Lucy H. Eddy, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tadashi Ito Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: (No Response) ********** Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-16312R1 PLOS One Dear Dr. Eddy, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tadashi Ito Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .